Vistagen Therapeutics, Inc. · NASDAQ:VTGN
Vistagen Therapeutics, Inc. shareholders
As of Jun 30, 2026, 47 institutions reported holding Vistagen Therapeutics, Inc., 28.7% of its shares. Largest: Commodore Capital LP, Vanguard and Two Sigma. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Vistagen Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Commodore Capital LP | 2.79M | 6.8% | new | Aug 14, 2026 |
| Vanguard | 1.8M | 4.4% | no change | Aug 13, 2026 |
| Two Sigma | 848K | 2.1% | +378K | Aug 14, 2026 |
| Acadian Asset Management LLC | 795K | 1.9% | +205K | Aug 13, 2026 |
| Renaissance Technologies | 731K | 1.8% | +439K | Aug 13, 2026 |
| Stempoint Capital LP | 617K | 1.5% | held for review | Aug 14, 2026 |
| Ikarian Capital, LLC | 519K | 1.3% | no change | Aug 14, 2026 |
| AdvisorShares Investments LLC | 439K | 1.1% | +162K | Aug 11, 2026 |
| Luminus Management LLC | 403K | 0.98% | +7,062 | Aug 14, 2026 |
| Geode Capital | 365K | 0.89% | −88,389 | Aug 12, 2026 |